Chmp1A and Its Role in Pancreatic Cancer Treatment with Retinoic Acid
Author Information
Author(s): Li Jing, Orr Brandon, White Kayla, Belogortseva Natalia, Niles Richard, Boskovic Goran, Nguyen Hanh, Dykes Ava, Park Maiyon
Primary Institution: Joan C. Edwards School of Medicine, Marshall University
Hypothesis
Is Chmp1A involved in ATRA-mediated growth inhibition of human pancreatic tumor cells?
Conclusion
Chmp1A mediates the growth inhibitory activity of ATRA in human pancreatic cancer cells via regulation of CRBP-1.
Supporting Evidence
- Chmp1A expression was increased upon ATRA treatment in pancreatic cancer cells.
- Knockdown of Chmp1A abolished ATRA-mediated growth inhibition.
- Chmp1A positively regulates the expression of CRBP-1, which is involved in retinoic acid metabolism.
Takeaway
Chmp1A helps stop pancreatic cancer cells from growing when treated with a substance called ATRA, which is related to vitamin A.
Methodology
Microarray studies, Western blot analysis, and cell culture experiments were performed to assess the effects of ATRA on pancreatic cancer cells.
Limitations
The study primarily focuses on in vitro experiments, which may not fully represent in vivo conditions.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website